If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email arsac@phe.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
This guidance to good clinical practice for nuclear medicine in the UK is the advice of the Administration of Radioactive Substances Advisory Committee (ARSAC).
These notes update the April 2020 edition to reflect the research application processfollowing the launch of the ARSAC online portal for research.
Published 17 April 2014 Last updated 1 September 2020 +show all updates
Added September 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.
Added April 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.
Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources'.
Updated notes to clarify the licencing process.
Replaced 'notes for guidance' document and updated detail text.
